Compare PBYI & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PBYI | NREF |
|---|---|---|
| Founded | 2010 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.4M | 258.6M |
| IPO Year | N/A | 2020 |
| Metric | PBYI | NREF |
|---|---|---|
| Price | $5.27 | $14.75 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 3 |
| Target Price | $7.00 | ★ $14.75 |
| AVG Volume (30 Days) | ★ 637.1K | 52.4K |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 13.71% |
| EPS Growth | 59.87 | ★ 132.43 |
| EPS | 0.74 | ★ 3.08 |
| Revenue | ★ $211,995,000.00 | $151,560,000.00 |
| Revenue This Year | N/A | $27.88 |
| Revenue Next Year | N/A | $5.41 |
| P/E Ratio | $7.10 | ★ $4.79 |
| Revenue Growth | N/A | ★ 107.15 |
| 52 Week Low | $2.58 | $12.14 |
| 52 Week High | $6.12 | $17.65 |
| Indicator | PBYI | NREF |
|---|---|---|
| Relative Strength Index (RSI) | 55.90 | 64.88 |
| Support Level | $4.84 | $14.22 |
| Resistance Level | $5.11 | $14.83 |
| Average True Range (ATR) | 0.19 | 0.29 |
| MACD | 0.04 | 0.08 |
| Stochastic Oscillator | 91.59 | 91.98 |
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.